Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
15.01
+0.21 (1.39%)
Jan 22, 2025, 10:58 AM EST - Market open
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for RDY stock has a target of 17, which predicts an increase of 13.30% from the current stock price of 15.01.
Analyst Consensus: Buy
* Price targets were last updated on Nov 6, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for RDY is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $17 → $17 | Buy | Maintains | $17 → $17 | +13.30% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +15.96% | Jul 30, 2024 |
| Barclays | Barclays | Buy Maintains $16 → $16 | Buy | Maintains | $16 → $16 | +7.96% | May 8, 2024 |
| Barclays | Barclays | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +6.63% | Jan 29, 2024 |
| Barclays | Barclays | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | -6.70% | Jun 1, 2023 |
Financial Forecast
Revenue This Year
324.92B
from 279.16B
Increased by 16.39%
Revenue Next Year
353.32B
from 324.92B
Increased by 8.74%
EPS This Year
69.59
from 66.80
Increased by 4.17%
EPS Next Year
73.93
from 69.59
Increased by 6.24%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 360.5B | 394.7B | 392.5B | ||
| Avg | 324.9B | 353.3B | 344.5B | ||
| Low | 257.0B | 286.7B | 276.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 29.1% | 21.5% | 11.1% | ||
| Avg | 16.4% | 8.7% | -2.5% | ||
| Low | -7.9% | -11.8% | -21.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 81.39 | 94.50 | 84.42 |
| Avg | 69.59 | 73.93 | 58.74 |
| Low | 37.73 | 49.00 | 37.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 21.8% | 35.8% | 14.2% |
| Avg | 4.2% | 6.2% | -20.5% |
| Low | -43.5% | -29.6% | -48.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.